NEW YORK, July 10 - Pfizer has asked ActivX Biosciences to help it "further characterize" the protein activity of a certain undisclosed research compound currently being developed at Pfizer, ActivX said today.

Financial terms of the agreement were not announced.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Under a proposed spending bill, the US National Institutes of Health would see an additional $3 billion in funding.

Researchers from the University of Oxford and the University of Sydney sequenced numerous platypus genomes to study their population history.

Robert Redfield, the new pick to lead the US Centers for Disease Control and Prevention, has faced criticism for some of his work.

In Nature this week: sequenced genomes of five additional Neanderthals, and more.